Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 52Fallopian Tube Neoplasms 48Endometrial Neoplasms 17Uterine Cervical Neoplasms 16Carcinoma, Ovarian Epithelial 15Brenner Tumor 15Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Esophageal Neoplasms 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Endometrial Adenocarcinoma 5Stomach Neoplasms 4Melanoma 4Lung Neoplasms 4Triple Negative Breast Neoplasms 3Testicular Neoplasms 3Prostatic Neoplasms 3Peritoneal Neoplasms 3Neoplasms 3Carcinoma, Renal Cell 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Sarcoma 2Salivary Gland Neoplasms 2Recurrence 2Platinum-Refractory Fallopian Tube Carcinoma 2Ovarian Germ Cell Cancer 2

Interventions

pembrolizumab 1X-Rays 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Congresses as Topic 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Adenocarcinoma × Taxes × Gynecologic × Clear all
NCT07061977 2026-06-05

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡